Pepscan achieves a breakthrough with CLIPS immunogen technology:
Today, Pepscan reports that it has achieved a major scientific breakthrough through the use of its CLIPS-based synthetic peptide immunogen technology.
Millipore Corp. has acquired BioAnaLab, a European-based services provider that specializes in the analysis of biologic drugs and vaccines.